Sales Nexus CRM

Therma Bright Accelerates Expansion in Growing Compression Therapy Market

By Advos

TL;DR

Therma Bright's Venowave VW5 offers a competitive edge with rapid Medicare reimbursement and expanding market presence.

Venowave VW5, a battery-powered compression device, improves vascular flow through peristaltic pump technology and lightweight design.

Therma Bright's innovative Venowave VW5 enhances patient care, increases accessibility, and fills the gap in mobile compression solutions.

Venowave VW5 increases venous blood flow by 64% in 2 minutes, providing a rapid and effective treatment option for patients.

Found this article helpful?

Share it with your network and spread the knowledge!

Therma Bright Accelerates Expansion in Growing Compression Therapy Market

Therma Bright Inc. is making significant strides in the compression therapy market, leveraging its Venowave VW5 device to capture opportunities in a sector projected to grow from $4.18 billion in 2024 to $6.72 billion by 2033.

The company has achieved notable milestones, including securing Medicare and Medicaid HCPCS Level II code reimbursements within 60 days. Over 110 Venowave VW5 units have been deployed across the United States, with 25 units already receiving full reimbursement through commercial and federal healthcare networks.

A strategic Letter of Intent with DME Authority, a Nashville-based distributor, underscores the company's expansion plans. The agreement includes an initial inventory purchase of $2 million, with partners committing to purchase $6 million worth of Venowave VW5 units in the first two quarters of 2025.

The Venowave VW5, a compact battery-operated peristaltic pump, offers significant clinical advantages. It increases venous blood flow by 64% within two minutes and 88% after 50 minutes of use. Its lightweight, wireless design enables patients to remain active during treatment, setting it apart from traditional compression therapies.

Major purchase orders from distributors like Valor Medical Solutions and DME Authority, totaling over $1.5 million, demonstrate growing market confidence. With its innovative approach and strategic positioning, Therma Bright is poised to capitalize on the expanding compression therapy market.

Curated from News Direct

blockchain registration record for this content
Advos

Advos

@advos